MassChallenge Startups Create Impact

2,458

Startups Accelerated

$6.2B

Funding Raised

$3B

Revenue Generated

157,000+

Jobs Created

Our startups

Be inspired. Search our startups.

Clear  
ChondroNest SA
ChondroNest SA

ChondroNest own patents in all key countries on the reconstruction of Extra Cellular Matrix based on modified Collagen and Glycosaminoglycans
This unique technology allows the reconstruction of cartilage, tendon, ligaments and bones. It is formulated as two components glue which solidify in patient in fully Bio-compatible conditions. This will allow the reconstruction of defects due to very serious and major conditions such as Osteochondritis and Osteoarthritis, multi billions medical affection
ChondroNest develop « In Vivo » reconstruction of cartilage Extra Cellular Matrix based on an injectable two component Bio-polymers

Connect with ChondroNest SA

2020

2020 Finalist Switzerland

Sub industry

Medical Devices

Additional Industries
Therapeutics (Pharma / Biotech)

Mission

MassChallenge strengthens the global innovation ecosystem by accelerating high-potential startups across all industries, from anywhere in the world.